Search results for: Potassium Permanganate Solution





Ocular Injury due to Potassium Permanganate Granules.
We report a rare case of ocular injury due to potassium permanganate (KMnO) granules in a child.
1254 related Products with: Ocular Injury due to Potassium Permanganate Granules.
Potassium Permanganate S
Potassium Permanganate S
6 para Toluidino 2 naphth
Potassium permanganate CA
Topoisomerase II; Clone
Topoisomerase II; Clone
Topoisomerase II; Clone
Potassium Ferrocyanide S
Potassium Ferrocyanide S
Potassium Ferrocyanide S
Potassium Ferrocyanide S
Potassium Ferrocyanide S
Related Pathways





Minimization of the perianal infection rate of hematological malignancies with agranulocytosis by quality control circle activity and patient-hospital-student win-win concept.
Objective The agranulocytosis-associated perianal infection (PI) rate ranges from 60% to 100% among patients with hematopoietic malignancies. In this study, we assessed the efficacy of a quality control circle (QCC) to minimize the PI rate. Methods Among 274 patients with severe immunodeficiency (agranulocytosis of ≥2 weeks) in our bone marrow transplantation center, the PI rate was 17.20%. A QCC was established following the 10 steps of the plan-do-check-act (PDCA) model; this was scientifically supported by culturing the bacterial colony from patients' perianal skin to determine the sanitization effect and interval time. Because a warm aqueous solution of potassium permanganate is recommended for sanitization, the bacterial colony culture was also used to determine the proper drug concentration, water temperature, and soaking time. All procedures were standardized. Patients, hospital staff, and medical students were enrolled into the QCC team based on the patient-hospital-student (PHS) win-win concept. Results After establishment of the PDCA model, the PI rate among 253 patients decreased from 17.20% to 5.93% and remained at 5.25% during the following year. The medical expenses and length of hospital stay consequently decreased. Conclusion The QCC and PHS win-win concept can reduce the PI rate and promote medical quality.
1128 related Products with: Minimization of the perianal infection rate of hematological malignancies with agranulocytosis by quality control circle activity and patient-hospital-student win-win concept.
Ofloxacin CAS Number [824
Syringe pump can be contr
EZH2 KMT6 Control Peptid
GFP control peptide anti
GFP Control Peptide
Rapid Microplate Assay K
BACTERIOLOGY BACTEROIDES
Androgen Receptor (Phosph
Androgen Receptor (Phosph
FMK Negative Control
FMK Negative Control 100
FMK Negative Control ; Ap
Related Pathways





[Curative effect of ozone hydrotherapy for pemphigus].
To determine clinical curative effects of ozone therapy for pemphigus vulgaris. Methods: Ozone hydrotherapy was used as an aid treatment for 32 patients with pemphigus vulgaris. The hydropathic compression of potassium permanganate solution for 34 patients with pemphigus vulgaris served as a control. The main treatment for both groups were glucocorticoids and immune inhibitors. The lesions of patients, bacterial infection, usage of antibiotics, patient's satisfaction, and clinical curative effect were evaluated in the 2 groups. Results: There was no significant difference in the curative effect and the average length of staying at hospital between the 2 groups (P>0.05). But rate for the usage of antibiotics was significantly reduced in the group of ozone hydrotherapy (P=0.039). The patients were more satisfied in using ozone hydrotherapy than the potassium permanganate solution after 7-day therapy (P>0.05). Conclusion: Ozone hydrotherapy is a safe and effective aid method for pemphigus vulgaris. It can reduce the usage of antibiotics.
1022 related Products with: [Curative effect of ozone hydrotherapy for pemphigus].
Cellufine Formyl , 50 ml
Cellufine Formyl Media
Cellufine Formyl , 500 ml
Cellufine Formyl Media
Cellufine Formyl Media
Formalin Solution (20%)
Formalin Solution (20%)
Formalin Solution (20%)
Formalin (10% Neutral Bu
Formalin (10% Neutral Bu
Zinc Formalin Solution
Zinc Formalin Solution
Related Pathways





Transformation of Methylparaben by aqueous permanganate in the presence of iodide: Kinetics, modeling, and formation of iodinated aromatic products.
This work investigated impacts of iodide (I) on the transformation of the widely used phenolic preservative methylparaben (MeP) as well as 11 other phenolic compounds by potassium permanganate (KMnO). It was found that KMnO showed a low reactivity towards MeP in the absence of I with apparent second-order rate constants (k) ranging from 0.065 ± 0.0071 to 1.0 ± 0.1 Ms over the pH range of 5-9. The presence of I remarkably enhanced the transformation rates of MeP by KMnO via the contribution of hypoiodous acid (HOI) in situ formed, which displayed several orders of magnitude higher reactivity towards MeP than KMnO. This enhancing effect of I was greatly influenced by solution conditions (e.g., I or KMnO concentration or pH), which could be well simulated by a kinetic model involving competition reactions (i.e., KMnO with I, KMnO with MeP, HOI with KMnO, and HOI with MeP). Similar enhancing effect of I on the transformation kinetics of 5 other selected phenols (i.e., p-hydroxybenzoic acid, phenol, and bromophenols) at pH 7 was also observed, but not in the cases of bisphenol A, triclosan, 4-n-nonylphenol, and cresols. This discrepancy could be well explained by the relative reactivity of KMnO towards phenols vs I. Liquid chromatography-tandem mass spectrometry analysis showed that iodinated aromatic products and/or iodinated quinone-like product were generated in the cases where I enhancing effect was observed. Evolution of iodinated aromatic products generated from MeP (10 μM) treated by KMnO (50-150 μM) in the presence of I (5-15 μM) suggested that higher I or moderate KMnO concentration or neutral pH promoted their formation. A similar enhancing effect of I (1 μM) on the transformation of MeP (1 μM) by KMnO (12.6 μM) and formation of iodinated aromatic products were also observed in natural water. This work demonstrates an important role of I in the transformation kinetics and product formation of phenolic compounds by KMnO, which has great implications for future applications of KMnO in treatment of I-containing water.
2600 related Products with: Transformation of Methylparaben by aqueous permanganate in the presence of iodide: Kinetics, modeling, and formation of iodinated aromatic products.
Ofloxacin CAS Number [824
Propidium iodide *10 mM a
Beta Amyloid (42) ELISA K
Beta Amyloid (1 40) ELISA
Beta Amyloid (40) ELISA K
Beta Amyloid (1 40) ELISA
Anti 3 DG imidazolone Mon
BYL-719 Mechanisms: PI3K-
Thermal Shaker with cooli
FDA Standard Frozen Tissu
FDA Standard Frozen Tissu
FDA Standard Frozen Tissu
Related Pathways





Growth and optimization of carbon nanotubes in powder activated carbon for an efficient removal of methylene blue from aqueous solution.
This work demonstrated the synthesis of carbon nanotubes (CNTs) on powder activated carbon (PAC) impregnated with Ni-catalyst through chemical vapour deposition. The optimized effects of reaction temperature, time and feedstock flow rates on CNT growth were examined. Potassium permanganate (KMnO) and potassium permanganate in acidic solution (KMnO/HSO) were used to functionalize CNTs samples. A primary screening of methylene blue (MB) adsorption was conducted. The chemical, physical and morphological properties of the adsorbent with the highest removal efficiency were investigated using FESEM, EDX, TEM, BET surface area, RAMAN, TGA, FTIR, and zeta potential. The resulting carbon nanotube-loaded activated carbons possessed abundant pore structure and large surface area. The MB removal by the as-synthesized CNTs was more remarkable than that by the modified samples. Adsorption studies were carried out to evaluate the optimum conditions, kinetics and isotherms for MB adsorption process. The response surface methodology-central composite design (RSM-CCD) was used to optimize the adsorption process parameters, including pH, adsorbent dosage and contact time. The investigation of the adsorption behaviour demonstrated that the adsorption was well fitted with the pseudo-second-order model and Langmuir isotherm with the maximum monolayer adsorption capacity of 174.5 mg/g. Meanwhile, the adsorption of MB onto adsorbent was driven by the electrostatic attraction and π-π interaction. Moreover, the as-obtained CNT-PAC exhibited good reusability after four repeated operations. In view of these empirical findings, the low-cost CNT-PAC has potential for removal of MB from aqueous solution.
2694 related Products with: Growth and optimization of carbon nanotubes in powder activated carbon for an efficient removal of methylene blue from aqueous solution.
Aniline Blue Solution
Aniline Blue Solution
Aniline Blue Solution
Methylene Blue Solution
Methylene Blue Solution
Methylene Blue Solution
Carbonic anhydrase 9 anti
Trypan Blue, sodium salt
IGF-1R Signaling Phospho-
Growth Factor (Human) Ant
Goat Anti-Human Fibroblas
Mouse anti human Carbonic
Related Pathways





Potassium permanganate cleansing is an effective sanitary method for the reduction of bacterial bioload on raw Coriandrum sativum.
Raw vegetables including flowers, leaves, stems, and roots are important carriers of food borne pathogens. We evaluated the bacteriological contamination of unwashed coriander leaves, and effectiveness of cleansing with 0.1% potassium permanganate solution as decontamination method.
2831 related Products with: Potassium permanganate cleansing is an effective sanitary method for the reduction of bacterial bioload on raw Coriandrum sativum.
MOUSE ANTI BORRELIA BURGD
MOUSE ANTI BOVINE ROTAVIR
RABBIT ANTI GSK3 BETA (pS
Rabbit Anti-KCNMB1 Maxi P
Rabbit Anti-KCNMB1 Maxi P
Rabbit Anti-KCNMB1 Maxi P
Rabbit Anti-KCNMB1 Maxi P
Rabbit Anti-KCNMB1 Maxi P
Rabbit Anti-KCNMB1 Maxi P
Rabbit Anti-KCNMB1 Maxi P
Rabbit Anti-KCNMB1 Maxi P
Rabbit Anti-KCNMB1 Maxi P
Related Pathways





Topical 5% potassium permanganate solution accelerates the healing process in chronic diabetic foot ulcers.
Potassium permanganate has been reported to be an effective treatment for certain types of wounds. The aim of the present study was to evaluate the use of potassium permanganate in the treatment of diabetic foot ulcers. A single-blind, randomized, controlled clinical trial was conducted on patients with type 2 diabetes mellitus that presented with a foot ulcer persisting for >3 months. The control group (n=10) was treated with the current standard treatment, which comprises of measures for reducing pressure in the ulcerated area, daily cleansing of the ulcer with potable water and antiseptic wash solution, and the application of a disinfectant solution on the entire surface area of the ulcer; while the intervention group (n=15) received the standard treatment plus 5% topical potassium permanganate solution applied once a day for 21 days. In the intervention group, 1 patient did not tolerate the treatment and was eliminated from the study on the first day. The remaining patients tolerated the interventions well. At the end of the treatment period, ulcers in the control group had decreased by 38% whereas those in the intervention group decreased by 73% (P<0.009). The degree of decrease was also investigated; the ulcer size was ≥50% decreased in 40% of patients in the control group and in 86% of patients in the intervention group (P=0.02). In conclusion, the results of the present study indicate that topical potassium permanganate is well tolerated and significantly accelerates the healing process of diabetic foot ulcers.
2092 related Products with: Topical 5% potassium permanganate solution accelerates the healing process in chronic diabetic foot ulcers.
Potassium Permanganate S
Potassium Permanganate S
BCIP INT Solution
BCIP INT Solution
BCIP INT Solution
Potassium Ferrocyanide S
Potassium Ferrocyanide S
Potassium Ferrocyanide S
Potassium Ferrocyanide S
Potassium Ferrocyanide S
Potassium Hydroxide Solu
Potassium Hydroxide Solu
Related Pathways





Treatment of soak liquor and bioelectricity generation in dual chamber microbial fuel cell.
The discharge of untreated soak liquor from tannery industry causes severe environmental pollution. This study is characterizing the soak liquor as a substrate in the microbial fuel cell (MFC) for remediation along with electricity generation. The dual chamber MFC was constructed and operated. Potassium permanganate was used as cathode solution and carbon felt electrode as anodic and cathodic material, respectively. The soak liquor was characterized by electrochemical studies viz., cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), and polarization studies, respectively. The removal percentage of protein, lipid, and chemical oxygen demand (COD) were measured before and after treatment with MFC. The results of MFC showed a highest current density of 300 mA/cm and a power density of 92 mW/m. The removal of COD, protein, and lipid were noted as 96, 81, and 97% respectively during MFC process. This MFC can be used in tannery industries for treating soak liquor and simultaneous electricity generation.
1152 related Products with: Treatment of soak liquor and bioelectricity generation in dual chamber microbial fuel cell.
Jurkat Cell Extract (Indu
Jurkat Cell Extract (Indu
Jurkat Cell Extract (Indu
Jurkat Cell Extract (Indu
Stat3 Peptide Inhibitor,
Stat3 Peptide Inhibitor,
Cell Meter™ Cell Viabil
Cell Meter™ Intracellul
Cell Meter™ Fluorimetri
Cell Meter™ Fluorimetri
AE 6220 Dual Slab Chamber
AE 6220 Dual Slab Chamber
Related Pathways





Remediation of arsenic(III) from aqueous solutions using zero-valent iron (ZVI) combined with potassium permanganate and ferrous ions.
A system of zerovalent iron combined with potassium permanganate and ferrous irons (Fe(II)-KMnO-ZVI) was used to remove As(III), one of the most poisonous wastewater pollutants. The Fe(II)-KMnO-ZVI system was characterized by using X-ray photoelectron spectroscopy and scanning electron microscopy. The As(III) removal efficiency by the Fe(II)-KMnO-ZVI system under different conditions was investigated and the experimental data were fitted to adsorption kinetics and isotherm models. As(III) could be removed by both physisorption and chemisorption through mixing adsorbents in a very short time (minute scale) with high removal ratios (more than 99.5%) over a wide range of pH (1-9) and concentration (20-100 mg/L). The removal of As(III) by the Fe(II)-KMnO-ZVI system agreed well with pseudo-first-order reaction kinetics and pseudo-second-order reaction kinetics. The Freundlich isotherm provided a good model of the adsorption system, indicating that the Fe(II)-KMnO-ZVI system has heterogeneous structure. The results show that the Fe(II)-KMnO-ZVI system exhibited a high removal efficiency for As(III), which suggested that it might be an effective material for As(III) remediation.
1761 related Products with: Remediation of arsenic(III) from aqueous solutions using zero-valent iron (ZVI) combined with potassium permanganate and ferrous ions.
Potassium Permanganate S
Potassium Permanganate S
Ammonium iron(III) sulfat
Iron (III) chloride hexah
Potassium permanganate CA
Ammonium iron (III) citra
Iron (III) chloride hexah
Acid Fuchsin (Aqueous)
Acid Fuchsin (Aqueous)
Aqueous Mount
Aqueous Mount
Aqueous Mount
Related Pathways





[Clinical application of pelvic floor reconstruction in extralevator abdominoperineal excision for low rectal cancer].
To investigate the safety and clinical significance of pelvic floor reconstruction in extralevator abdominoperineal excision(ELAPE) for advanced low rectal cancer.
1279 related Products with: [Clinical application of pelvic floor reconstruction in extralevator abdominoperineal excision for low rectal cancer].
Rectal cancer test tissue
Multiple organ cancer tis
Lung cancer tissue array
Colon cancer and normal t
Colon cancer and normal t
Colon cancer, metastasize
Colon cancer and matched
Colon cancer tissue array
Kidney cancer tissue arra
Ovary cancer tissue array
Bladder cancer tissue arr
Prostate cancer, adjacent
Related Pathways
Contact Us:
Belgium
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45 Fax 0032 16 50 90 45
info@gentaur.com
France
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50 Fax 01 43 25 01 60
france@gentaur.com
Germany
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Tel 0241 40 08 90 86 Fax 0241 55 91 05 36
de@gentaur.com
United Kingdom
GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com
Also in
Luxembourg +35220880274
Schweiz Züri +41435006251
Danmark +4569918806
Österreich +43720880899
Česká republika Praha +420246019719
Ireland Dublin +35316526556
Norge Oslo +4721031366
Finland Helsset +358942419041
Sverige Stockholm +46852503438
Ελλάς Αθήνα +302111768494
Magyarország Budapest +3619980547
Poland
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
Tel 058 710 33 44
Fax 058 710 33 48
poland@gentaur.com
skype gentaurpoland
Nederland
GENTAUR Nederland BV
Kuiper 1
5521 DG Eersel Nederland
Tel 0208-080893 Fax 0497-517897
nl@gentaur.com
Italy
GENTAUR SRL
IVA IT03841300167
Piazza Giacomo Matteotti, 6, 24122 Bergamo
Tel 02 36 00 65 93 Fax 02 36 00 65 94
italia@gentaur.com
Spain
GENTAUR Spain
Tel 0911876558
spain@gentaur.com
Bulgaria
GENTAUR Bulgaria
53 Iskar Str. 1191 Kokalyane, Sofia
Sofia 1000
Tel 0035924682280
Fax 0035929830072
sofia@gentaur.com